Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Cell Stem Cell
|
June 29, 2023
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion
Hans Jiro Becker, Reiko Ishida, Adam C Wilkinson, et al.
International Journal of Environmental Research and Public Health
|
April 30, 2021
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
Tatsuya Yoshihara, Kazuya Ito, Masayoshi Zaitsu, et al.
Cancer Science
|
February 8, 2022
CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression
Xiaoxiao Liu, Naru Sato, Yuko Shimosato, et al.
Communications Biology
|
November 23, 2021
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer
Shinichi Namba, Toshihide Ueno, Shinya Kojima, et al.
Human Vaccines & Immunotherapeutics
|
June 26, 2023
Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination
Megumi Hara, Takeki Furue, Mami Fukuoka, et al.
Vaccines
|
May 28, 2022
Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case-Control Study
Megumi Hara, Takeki Furue, Mami Fukuoka, et al.
Nature Communications
|
October 27, 2019
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
Yasutaka Hayashi, Susumu Goyama, XiaoXiao Liu, et al.
NPJ Precision Oncology
|
December 9, 2023
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia
Bunpei Miyazaki, Toshihide Ueno, Masanaka Sugiyama, et al.
Nature Biotechnology
|
February 10, 2015
Decoding the regulatory network of early blood development from single-cell gene expression measurements
Victoria Moignard, Steven Woodhouse, Laleh Haghverdi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2021
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632
Rintaro Noro, Satoshi Igawa, Akihiro Bessho, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Cell Stem Cell
|
June 29, 2023
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion
Hans Jiro Becker, Reiko Ishida, Adam C Wilkinson, et al.
International Journal of Environmental Research and Public Health
|
April 30, 2021
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
Tatsuya Yoshihara, Kazuya Ito, Masayoshi Zaitsu, et al.
Cancer Science
|
February 8, 2022
CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression
Xiaoxiao Liu, Naru Sato, Yuko Shimosato, et al.
Communications Biology
|
November 23, 2021
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer
Shinichi Namba, Toshihide Ueno, Shinya Kojima, et al.
Human Vaccines & Immunotherapeutics
|
June 26, 2023
Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination
Megumi Hara, Takeki Furue, Mami Fukuoka, et al.
Vaccines
|
May 28, 2022
Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case-Control Study
Megumi Hara, Takeki Furue, Mami Fukuoka, et al.
Nature Communications
|
October 27, 2019
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
Yasutaka Hayashi, Susumu Goyama, XiaoXiao Liu, et al.
NPJ Precision Oncology
|
December 9, 2023
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia
Bunpei Miyazaki, Toshihide Ueno, Masanaka Sugiyama, et al.
Nature Biotechnology
|
February 10, 2015
Decoding the regulatory network of early blood development from single-cell gene expression measurements
Victoria Moignard, Steven Woodhouse, Laleh Haghverdi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2021
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632
Rintaro Noro, Satoshi Igawa, Akihiro Bessho, et al.
Page
of 22